EDP Sciences and the Société Française de Radioprotection (SFRP) have decided against transitioning Radioprotection to open access under Subscribe to Open (S2O) in 2023. Despite concerted efforts to promote the initiative and reach the required subscription threshold, the financial viability of the transition was not achieved at this time. This decision underscores the reality that open access for S2O journals is not guaranteed unless subscriptions are renewed.
Despite extending the assessment window, the required subscriptions for Radioprotection were not received and, with regret, the decision has been made to keep the content only accessible to subscribers. Radioprotection will, therefore, remain under subscriber-only access in 2023.
While the journal will remain in closed access in 2023, it is important to emphasize the benefits of S2O. The S2O model provides an opportunity for authors to publish their research without article processing charges (APCs) and enables readers to access content free of charge.
Radioprotection remains committed to delivering high-quality research in the field of radiation protection and the journal's editorial board, along with EDP Sciences, will continue to explore opportunities for advancing open access initiatives and fostering greater dissemination of scientific knowledge in the future. In the meantime, Radioprotection remains in ‘Green’ open access, so compliant with Plan S. Authors wishing to publish in open access in Radioprotection can continue to do so via the open access option.
Radioprotection is a peer-reviewed journal published by EDP Sciences on behalf of the Société Française de Radioprotection (SFRP). Articles are in English and French and address all aspects of radiological protection, including non-ionising as well as ionising radiations. Fields of interest range from research, development and theory to operational matters, education and training. Topics include (theoretical and practical aspects): dosimetry, instrument development, specialized measuring techniques, epidemiology, biological effects (in vivo and in vitro) and risk and environmental impact assessments.
Click here to read the original press release.
